Researchers in the UK Dementia Research Institute at the University of Cambridge in the UK focused ... by the build-up in the ...

Currently, three medications have been approved by the Food and Drug Administration (FDA) to help slow the biological changes associated with certain types of dementia, such as Alzheimer’s ...

Dementia, affecting over 55 million globally, primarily results from diseases like Alzheimer's. It leads to memory loss, mood ...

A drug commonly used to treat glaucoma has been shown in zebrafish and mice to protect against the build-up in the brain of ...

The drug works by essentially forcing our cells to "spit out" dangerous protein clumps involved in Alzheimer's.

Researchers have discovered that methazolamide, a glaucoma drug, can clear tau protein build-up in the brain, a key factor in dementias like Alzheimer's. This study, using zebrafish and mice models, s ...

Some Diabetes Drugs Tied to Lower Risk of Dementia ... Epigenetics Blood Markers Can Help Explain Dementia Risk Aug. 28, 2024 — Researchers assessed DNA methylation at 800,000 sites in the ...

Obstructive sleep apnea is a common condition that impacts about 39 million adults in the U.S. But if it’s left untreated, it ...

Nilotinib (Tasigna) — a drug for myeloid leukemia — improved biomarkers and cognitive outcomes in study participants with dementia with Lewy bodies, a new study finds.

People who maintain or start physical activity of any intensity after receiving a dementia diagnosis may be at a decreased ...